Targeting cardiac sympatho-vagal imbalance using gene transfer of nitric oxide synthase

Journal of Molecular and Cellular Cardiology

Volumn 46, Issue 4, 2009, Pages 482-489

  Danson, E J ^a   Li, D ^a   Wang, L ^a   Dawson, T A ^a   Paterson, D J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Autonomic imbalance; Heart rate; Hypertension; Myocardial ischemia; Nitric oxide

Indexed keywords

ANGIOTENSIN II; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE; REACTIVE OXYGEN METABOLITE;

ADRENERGIC SYSTEM; AUTONOMIC DYSFUNCTION; CALCIUM TRANSPORT; CARDIOVASCULAR DISEASE; GENE TRANSFER; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART RATE VARIABILITY; HUMAN; HYPERTENSION; NEUROTRANSMISSION; NONHUMAN; OXIDATIVE STRESS; PARASYMPATHETIC FUNCTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION;

ANGIOTENSIN II; ANIMALS; GENE THERAPY; HUMANS; MYOCARDIUM; NITRIC OXIDE SYNTHASE; SYMPATHETIC NERVOUS SYSTEM; VAGUS NERVE;

EID: 61449218738     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2008.12.013     Document Type: Review

References (78)

1. Jouven X., Empana J.P., Schwartz P.J., Desnos M., Courbon D., and Ducimetière P. Heart-rate profile during exercise as a predictor of sudden death. N. Engl. J. Med. 352 19 (2005) 1951-1958
2. Palatini P., and Julius S. Elevated heart rate: a major risk factor for cardiovascular disease. Clin. Exp. Hypertens. 26 7-8 (2004) 637-644
3. Fox K., Borer J.S., Camm A.J., Danchin N., Ferrari R., Lopez Sendon J.L., et al. Heart Rate Working Group. J. Am. Coll. Cardiol. 50 9 (2007) 823-830
4. Langewitz W., Rüddel H., and Schächinger H. Reduced parasympathetic cardiac control in patients with hypertension at rest and under mental stress. Am. Heart J. 127 1 (1994) 122-128
5. Davrath L.R., Goren Y., Pinhas I., Toledo E., and Akselrod S. Early autonomic malfunction in normotensive individuals with a genetic predisposition to essential hypertension. Am. J. Physiol. Heart Circ. Physiol. 285 4 (2003) H1697-H1704
6. Airaksinen K.E., Tahvanainen K.U., Eckberg D.L., Niemelä M.J., Ylitalo A., and Huikuri H.V. Arterial baroreflex impairment in patients during acute coronary occlusion. J. Am. Coll. Cardiol. 32 6 (1998) 1641-1647
7. Cole C.R., Blackstone E.H., Pashkow F.J., Snader C.E., and Lauer M.S. Heart-rate recovery immediately after exercise as a predictor of mortality. N. Engl. J. Med. 341 (1999) 1351-1357
8. Cohn J.N., Levine T.B., Olivari M.T., Garberg V., Lura D., Francis G.S., et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N. Engl. J. Med. 311 (1984) 819-823
9. Vanoli E., Adamson P.B., Foreman R.D., and Schwartz P.J. Prediction of unexpected sudden death among healthy dogs by a novel marker of autonomic neural activity. Heart Rhythm 5 2 (2008) 300-305
10. Vanoli E., De Ferrari G.M., Stramba-Badiale M., Hull Jr. S.S., Foreman R.D., and Schwartz P.J. Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction. Circ. Res. 68 5 (1991) 1471-1481
11. Tai M.H., Hsiao M., Chan J.Y., Lo W.C., Wang F.S., Liu G.S., et al. Gene delivery of endothelial nitric oxide synthase into nucleus tractus solitarii induces biphasic response in cardiovascular functions of hypertensive rats. Am. J. Hypertens. 17 1 (2004) 63-70
12. Waki H., Murphy D., Yao S.T., Kasparov S., and Paton J.F. Endothelial NO synthase activity in nucleus tractus solitarii contributes to hypertension in spontaneously hypertensive rats. Hypertension 48 4 (2006) 644-650
13. Paton J.F., Kasparov S., and Paterson D.J. Nitric oxide and autonomic control of heart rate: a question of specificity. Trends Neurosci. 25 12 (2002) 626-631
14. Schroeder E.B., Liao D., Chambless L.E., Prineas R.J., Evans G.W., and Heiss G. Hypertension, blood pressure, and heart rate variability. Hypertension 42 (2003) 1106-1111
15. Bigger Jr. J.T., Fleiss J.L., Steinman R.C., Rolnitzky L.M., Schneider W.J., and Stein P.K. RR variability in healthy, middle-aged persons compared with patients with chronic coronary heart disease or recent acute myocardial infarction. Circulation 91 7 (1995) 1936-1943
16. Nishime E.O., Cole C.R., Blackstone E.H., Pashkow F.J., and Lauer M.S. Heart rate recovery and treadmill exercise score as predictors of mortality in patients referred for exercise ECG. JAMA 284 11 (2000) 1392-1398
17. Agarwal A., Williams G.H., and Fisher N.D. Genetics of human hypertension. Trends Endocrinol. Metab. 16 3 (2005) 127-133
18. Okamoto K., and Aoki K. Development of a strain of spontaneously hypertensive rats. Jpn. Circ. J. 27 (1963) 282-293
19. Kawabe K., Watanabe T.X., Shiono K., and Sokabe H. Influence on blood pressure of renal isografts between spontaneously hypertensive and normotensive rats, utilizing the F1 hybrids. Jpn. Heart J. 19 6 (1978) 886-894
20. Abboud F.M. The sympathetic system in hypertension. State-of-the-art review. Hypertension 4 3 Pt 2 (1982) 208-225
21. Kuo T.B., and Yang C.C. Altered frequency characteristic of central vasomotor control in SHR. Am. J. Physiol. Heart Circ. Physiol. 278 1 (2000) H201-H207
22. O'Connor D.T., Takiyyuddin M.A., Printz M.P., Dinh T.Q., Barbosa J.A., Rozansky D.J., et al. Catecholamine storage vesicle protein expression in genetic hypertension. Blood Press. 8 5-6 (1999) 285-295
23. Tsunoda M., Takezawa K., Santa T., Ina Y., Nagashima K., Ohmori K., et al. New approach for measurement of sympathetic nervous abnormality in conscious, spontaneously hypertensive rats. Jpn. J. Pharmacol. 83 1 (2000) 39-45
24. Katovich M.J., Barney C.C., and Fregly M.J. Metabolic responsiveness of spontaneously hypertensive rat to isoproterenol. Am. J. Physiol. 241 4 (1981) H497-504
25. Saragoca M., and Tarazi R.C. Impaired cardiac contractile response to isoproterenol in the spontaneously hypertensive rat. Hypertension 3 3 (1981) 380-385
26. Heaton D.A., Lei M., Li D., Golding S., Dawson T.A., Mohan R.M., et al. Remodeling of the cardiac pacemaker L-type calcium current and its beta-adrenergic responsiveness in hypertension after neuronal NO synthase gene transfer. Hypertension 48 3 (2006) 443-452
27. Chandler M.P., and DiCarlo S.E. Acute exercise and gender alter cardiac autonomic tonus differently in hypertensive and normotensive rats. Am. J. Physiol. 274 2 Pt 2 (1998) R510-R516
28. Heaton D.A., Li D., Almond S.C., Dawson T.A., Wang L., Channon K.M., et al. Gene transfer of neuronal nitric oxide synthase into intracardiac ganglia reverses vagal impairment in hypertensive rats. Hypertension 49 2 (2007) 380-388
29. Herring N., Lokale M.N., Danson E.J., Heaton D.A., and Paterson D.J. Neuropeptide Y reduces acetylcholine release and vagal bradycardia via a Y2 receptor-mediated, protein kinase C-dependent pathway. J. Mol. Cell. Cardiol. 44 3 (2008) 477-485
30. Lazartigues E., Brefel-Courbon C., Tran M.A., Montastruc J.L., and Rascol O. Spontaneously hypertensive rats cholinergic hyper-responsiveness: central and peripheral pharmacological mechanisms. Br. J. Pharmacol. 127 7 (1999) 1657-1665
31. Du X.J., Cox H.S., Dart A.M., and Esler M.D. Depression of efferent parasympathetic control of heart rate in rats with myocardial infarction: effect of losartan. J. Cardiovasc. Pharmacol. 31 6 (1998) 937-944
32. Módolo Rda P., Bernardes C.F., Vasquez E.C., and Mill J.G. Evaluation of the vagal efferent pathway in rats in the acute and chronic phases of myocardial infarction. Arq. Bras. Cardiol. 65 1 (1995) 17-22
33. Balligand J.L., Kelly R.A., Marsden P.A., Smith T.W., and Michel T. Control of cardiac muscle cell function by an endogenous nitric oxide signaling system. Proc. Natl. Acad. Sci. U. S. A. 90 1 (1993) 347-351
34. Han X., Kubota I., Feron O., Opel D.J., Arstall M.A., Zhao Y.Y., et al. Muscarinic cholinergic regulation of cardiac myocyte ICa-L is absent in mice with targeted disruption of endothelial nitric oxide synthase. Proc. Natl. Acad. Sci. U. S. A. 95 11 (1998) 6510-6515
35. Vandecasteele G., Eschenhagen T., Scholz H., Stein B., Verde I., and Fischmeister R. Muscarinic and beta-adrenergic regulation of heart rate, force of contraction and calcium current is preserved in mice lacking endothelial nitric oxide synthase. Nat. Med. 5 3 (1999) 331-334
36. Wei C., Jiang S., Lust J.A., Daly R.C., and McGregor C.G. Genetic expression of endothelial nitric oxide synthase in human atrial myocardium. Mayo Clin. Proc. 71 4 (1996) 346-350
37. Choate J.K., Danson E.J., Morris J.F., and Paterson D.J. Peripheral vagal control of heart rate is impaired in neuronal NOS knockout mice. Am. J. Physiol. Heart Circ. Physiol. 281 6 (2001) H2310-H2317
38. Herring N., and Paterson D.J. Nitric oxide-cGMP pathway facilitates acetylcholine release and bradycardia during vagal nerve stimulation in the guinea-pig in vitro. J. Physiol. 535 Pt 2 (2001) 507-518
39. Massion P.B., Dessy C., Desjardins F., Pelat M., Havaux X., Belge C., et al. Cardiomyocyte-restricted overexpression of endothelial nitric oxide synthase (NOS3) attenuates beta-adrenergic stimulation and reinforces vagal inhibition of cardiac contraction. Circulation 110 17 (2004) 2666-2672
40. Danson E.J., Zhang Y.H., Sears C.E., Edwards A.R., Casadei B., and Paterson D.J. Disruption of inhibitory G-proteins mediates a reduction in atrial beta-adrenergic signaling by enhancing eNOS expression. Cardiovasc. Res. 67 4 (2005) 613-623
41. Belge C., Massion P.B., Pelat M., and Balligand J.L. Nitric oxide and the heart: update on new paradigms. Ann. N. Y. Acad. Sci. 1047 (2005) 173-182
42. Martin S.R., Emanuel K., Sears C.E., Zhang Y.H., and Casadei B. Are myocardial eNOS and nNOS involved in the beta-adrenergic and muscarinic regulation of inotropy? A systematic investigation. Cardiovasc. Res. 70 1 (2006) 97-106
43. Schwarz P., Diem R., Dun N.J., and Förstermann U. Endogenous and exogenous nitric oxide inhibits norepinephrine release from rat heart sympathetic nerves. Circ. Res. 77 4 (1995) 841-848
44. Balligand J.-L. Regulation of cardiac beta adrenergic response by nitric oxide. Cardiovasc Res 43 (1999) 607-620
45. Zhang Y.H., Zhang M.H., Sears C.E., Emanuel K., Redwood C., El-Armouche A., et al. Reduced phospholamban phosphorylation is associated with impaired relaxation in left ventricular myocytes from neuronal NO synthase-deficient mice. Circ. Res. 102 2 (2008) 242-249
46. Barouch L.A., Harrison R.W., Skaf M.W., Rosas G.O., Cappola T.P., Kobeissi Z.A., et al. Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms. Nature 416 6878 (2002) 337-339
47. Zanzinger J., Czachurski J., and Seller H. Neuronal nitric oxide reduces sympathetic excitability by modulation of central glutamate effects in pigs. Circ. Res. 80 4 (1997) 565-571
48. Sällström J., Carlström M., Jensen B.L., Skøtt O., Brown R.D., and Persson A.E. Neuronal nitric oxide synthase-deficient mice have impaired renin release but normal blood pressure. Am. J. Hypertens. 21 1 (2008) 111-116
49. Shesely E.G., Maeda N., Kim H.S., Desai K.M., Krege J.H., Laubach V.E., et al. Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proc. Natl. Acad. Sci. U. S. A. 93 23 (1996) 13176-13181
50. Jumrussirikul P., Dinerman J., Dawson T.M., Dawson V.L., Ekelund U., Georgakopoulos D., et al. Interaction between neuronal nitric oxide synthase and inhibitory G protein activity in heart rate regulation in conscious mice. J. Clin. Invest. 102 7 (1998) 1279-1285
51. Carvalho T.H., Lopes O.U., and Tolentino-Silva F.R. Baroreflex responses in neuronal nitric oxide synthase knoukout mice (nNOS). Auton. Neurosci. 126-127 (2006) 163-168
52. Zheng H., Li Y.F., Cornish K.G., Zucker I.H., and Patel K.P. Exercise training improves endogenous nitric oxide mechanisms within the paraventricular nucleus in rats with heart failure. Am. J. Physiol. Heart Circ. Physiol. 288 5 (2005) H2332-H2341
53. Li Y.F., Roy S.K., Channon K.M., Zucker I.H., and Patel K.P. Effect of in vivo gene transfer of nNOS in the PVN on renal nerve discharge in rats. Am. J. Physiol. Heart Circ. Physiol. 282 2 (2002) H594-H601
54. Wang Y., Liu X.F., Cornish K.G., Zucker I.H., and Patel K.P. Effects of nNOS antisense in the paraventricular nucleus on blood pressure and heart rate in rats with heart failure. Am. J. Physiol. Heart Circ. Physiol. 288 1 (2005) H205-H213
55. Paton J.F., Deuchars J., Ahmad Z., Wong L.F., Murphy D., and Kasparov S. Adenoviral vector demonstrates that angiotensin II-induced depression of the cardiac baroreflex is mediated by endothelial nitric oxide synthase in the nucleus tractus solitarii of the rat. J. Physiol. 531 Pt 2 (2001) 445-458
56. Sakai K., Hirooka Y., Matsuo I., Eshima K., Shigematsu H., Shimokawa H., et al. Overexpression of eNOS in NTS causes hypotension and bradycardia in vivo. Hypertension 36 6 (2000) 1023-1028
57. Li D., Wang L., Lee C.W., Dawson T.A., and Paterson D.J. Noradrenergic cell specific gene transfer with neuronal nitric oxide synthase reduces cardiac sympathetic neurotransmission in hypertensive rats. Hypertension 50 1 (2007) 69-74
58. Zanzinger J., and Czachurski J. Chronic oxidative stress in the RVLM modulates sympathetic control of circulation in pigs. Pflugers Arch. 439 4 (2000) 489-494
59. Kishi T., Hirooka Y., Kimura Y., Ito K., Shimokawa H., and Takeshita A. Increased reactive oxygen species in rostral ventrolateral medulla contribute to neural mechanisms of hypertension in stroke-prone spontaneously hypertensive rats. Circulation 109 19 (2004) 2357-2362
60. Dawson T.A., Li D., Woodward T., Barber Z., Wang L., and Paterson D.J. Cardiac cholinergic NO-cGMP signaling following acute myocardial infarction and nNOS gene transfer. Am. J. Physiol. Heart Circ. Physiol. 295 3 (2008) H990-H998
61. Paolocci N., Biondi R., Bettini M., Lee C.I., Berlowitz C.O., Rossi R., et al. Oxygen radical-mediated reduction in basal and agonist-evoked NO release in isolated rat heart. J. Mol. Cell. Cardiol. 33 4 (2001 Apr) 671-679
62. Sanderford M.G., and Bishop V.S. Angiotensin II acutely attenuates range of arterial baroreflex control of renal sympathetic nerve activity. Am. J. Physiol. Heart Circ. Physiol. 279 4 (2000) H1804-H1812
63. Balt J.C., Mathy M.J., Nap A., Pfaffendorf M., and van Zwieten P.A. Effect of the AT1-receptor antagonists losartan, irbesartan, and telmisartan on angiotensin II-induced facilitation of sympathetic neurotransmission in the rat mesenteric artery. J. Cardiovasc. Pharmacol. 38 1 (2001) 141-148
64. Lazartigues E., Dunlay S.M., Loihl A.K., Sinnayah P., Lang J.A., Espelund J.J., et al. Brain-selective overexpression of angiotensin (AT1) receptors causes enhanced cardiovascular sensitivity in transgenic mice. Circ. Res. 90 5 (2002) 617-624
65. Griendling K.K., Minieri C.A., Ollerenshaw J.D., and Alexander R.W. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ. Res. 74 6 (1994) 1141-1148
66. Zimmerman M.C., Lazartigues E., Lang J.A., Sinnayah P., Ahmad I.M., Spitz D.R., et al. Superoxide mediates the actions of angiotensin II in the central nervous system. Circ. Res. 91 11 (2002) 1038-1045
67. Pan Y.X., Gao L., Wang W.Z., Zheng H., Liu D., Patel K.P., et al. Exercise training prevents arterial baroreflex dysfunction in rats treated with central angiotensin II. Hypertension 49 3 (2007) 519-527
68. Gao L., Wang W., Wang W., Li H., Sumners C., and Zucker I.H. Effects of angiotensin type 2 receptor overexpression in the rostral ventrolateral medulla on blood pressure and urine excretion in normal rats. Hypertension 51 2 (2008) 521-527
69. Monahan K.D., Eskurza I., and Seals D.R. Ascorbic acid increases cardiovagal baroreflex sensitivity in healthy older men. Am. J. Physiol. Heart Circ. Physiol. 286 6 (2004) H2113-H2117
70. Ziegler D., Schatz H., Conrad F., Gries F.A., Ulrich H., and Reichel G. Effects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN Study). Deutsche Kardiale Autonome Neuropathie. Diabetes Care 20 3 (1997) 369-373
71. Kishi T., Hirooka Y., Mukai Y., Shimokawa H., and Takeshita A. Atorvastatin causes depressor and sympatho-inhibitory effects with upregulation of nitric oxide synthases in stroke-prone spontaneously hypertensive rats. J. Hypertens. 21 2 (2003) 379-386
72. Heaton D.A., Golding S., Bradley C.P., Dawson T.A., Cai S., Channon K.M., et al. Targeted nNOS gene transfer into the cardiac vagus rapidly increases parasympathetic function in the pig. J. Mol. Cell. Cardiol. 39 1 (2005) 159-164
73. Li Y.F., Roy S.K., Channon K.M., Zucker I.H., and Patel K.P. Effect of in vivo gene transfer of nNOS in the PVN on renal nerve discharge in rats. Am. J. Physiol. Heart Circ. Physiol. 282 2 (2002) H594-601
74. Hwang D.Y., Carlezon Jr. W.A., Isacson O., and Kim K.S. A high-efficiency synthetic promoter that drives transgene expression selectively in noradrenergic neurons. Hum. Gene Ther. 12 14 (2001) 1731-1740
75. Wang L., Li D., Plested C.P., Dawson T., Teschemacher A.G., and Paterson D.J. Noradrenergic neuron-specific overexpression of nNOS in cardiac sympathetic nerves decreases neurotransmission. J. Mol. Cell. Cardiol. 41 2 (2006) 364-370
76. Li D., Wang L., Lee C.W., Dawson T.A., and Paterson D.J. Noradrenergic cell specific gene transfer with neuronal nitric oxide synthase reduces cardiac sympathetic neurotransmission in hypertensive rats. Hypertension 50 1 (2007) 69-74
77. Wang L., Henrich M., Buckler K.J., McMenamin M., Mee C.J., Sattelle D.B., et al. Neuronal nitric oxide synthase gene transfer decreases [Ca2+]i in cardiac sympathetic neurons. J. Mol. Cell. Cardiol. 43 6 (2007) 717-725
78. Bendall J.K., Alp N.J., Warrick N., Cai S., Adlam D., Rockett K., et al. Stoichiometric relationships between endothelial tetrahydrobiopterin, endothelial NO synthase (eNOS) activity, and eNOS coupling in vivo: insights from transgenic mice with endothelial-targeted GTP cyclohydrolase 1 and eNOS overexpression. Circ. Res. 97 9 (2005) 864-871